Omeprazole 20MG & Domperidone 10MG Pellets Capsule - A multi particulate oral dosage form containing two active pharmaceutical ingredients (APIs) in pellet-based capsule formulation. The formulation involves balancing various parameters – active-ingredient dosage, pellet excipient preparation, functional coating, pellet release, and capsule filling. For pharma companies producing combination oral dosage forms, this formulation can easily be added to a PCD Pharma Franchise range with the proper manufacturing and quality control mechanisms.
When pellets are used, the formulation can accommodate individual active ingredients by means of a series of controlled process steps prior to final capsule filling. Due to the susceptibility of Omeprazole to acid, it typically needs a suitable formulation approach for protection, with domperidone component needing its own formulation and release requirements.
According to the approved product design, separate pellet streams can be produced for each of the active substances. The pellet formulations can then be processed and coated based on their individual needs before being mixed in the final capsule.
This enables formulation developers to have the ability to precisely dictate particle properties, coat behaviour and release performance far better than a straightforward powder-filled capsule.
As for the omeprazole component, pellets can be developed with an active-containing core and then coated with protective and functional coating layers. The design of the coating system has to be based on the requested stability and release profile of the finished product.
The development parameters include the pellet size distribution, surface properties, coating uniformity and hardening. To ensure consistent formation of films during the coating process the spray rate, atomization, drying conditions, flow of air and temperature are maintained.
The coated pellets after processing can be tested for their resistance when exposed to appropriate test conditions and for their subsequent release profile. Coating control is necessary as variable coating thickness affects the dissolution profile.
The domperidone component can be blended into a pellet system prepared separately in accordance with the final formulation design. The choice of excipients and process parameters are chosen based on the final pellet characteristics and the desired release profile.
One of the key parameters influencing the physical properties of the pellet are particle size, density, flow properties and surface composition to ensure smooth processing. When different population of pellets are going to be mixed then their physical properties should be comparable to decrease the segregation during filling into the capsule.
The pellet preparation is blended together in a controlled way to ensure that the ratio of the two components is maintained. Representative samples can be tested to confirm that distribution has been achieved prior to the feeding of the material into the encapsulation step.
After the pellet systems have been checked within the manufacturing process, they are filled into appropriately sized hard capsule shells. The filling process is automated and regulated by the density and flow behaviour of the pellet systems, as well as by the respective capsule size and fill weight.
During production, it is possible to keep track of: Weight variation, locking of the capsules, shell integrity, the appearance and uniformity of fill. As the pellets are sensitive to mechanical stress, good care should be taken, as the functional coating layer may be damaged.
The finished-product dissolution testing can be used to assess the release of the multiparticulates. The release of omeprazole and domperidone might be characterized as part of a specific analytical procedure according to the product specification.
Quality Control of Omeprazole 20MG & Domperidone 10MG Pellets Capsule: The quality control of Omeprazole 20 MG & Domperidone 10 MG Pellets Capsule involves the physical and active component assessment of the multiparticulate system. The tests to be carried out could be Assay, related substances, uniformity of dosage units, identification, dissolution, pellet evaluation and moisture.
The analytical methods should demonstrate appropriate selectivity for the two active ingredients when assayed together in the same finished dosage form. Method validation or qualification is in support of appropriate testing.
Stability studies may include assay, related substances, dissolution profile, moisture, appearance of the capsule and pellet intactness, and performance of the pack. Particular observation should be made on the environmental conditions which may affect the coated pellet system.
Packaging for Omeprazole 20MG & Domperidone 10MG Pellets Capsule Packaging should offer suitable protection against the danger of external environment as well as the stability of the capsule along with the coated pellets. Blister/strip packaging system may also be considered.
The results of packaging compatibility studies can evaluate the ability of the different package components to maintain seal integrity, evaluate the interaction of materials with the medicinal product and evaluate the protection afforded the medicinal product in storage and transit. Stability information can then assist in the final packaging design and storage conditions.
This multi particulate capsule can be included in a specialised combination range, supported by specific raw material monographs, pellet manufacturing, analytical testing and stability studies should this be used by any of the PCD Pharma Franchise Companies.
Whether it is separating pellet preparation and functional coating, controlled blending, capsule filling, dissolution profiling, stability tracking, or protective packaging, they all can impact quality of the final product. A well-designed multi particulate system can help to preserve the desired integrity of Omeprazole 20MG & Domperidone 10MG Pellets Capsule and its defined content and release profile during the recommended shelf life.
Omeprazole 20MG + Domperidone 10MG Pellets Capsule formulation, pellet coating, manufacturing, quality control, stability and packaging.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech